The literature on the serological complement system in schizophrenia is large but characterized by small samples, variable methodological approaches, clinical diversity of cohorts, failure to assay C4A and C4B separately in most studies, and inconsistent results [2, 3, 27]. The gene discussed is C4A; the disease is schizophrenia.